Editing the Human Genome
By BBC Newshour Extra,
BBC Newshour Extra
| 11. 28. 2015
Remarkable new techniques for ‘editing’ DNA – chemically cutting and splicing sections of genetic code – are revolutionising research in laboratories around the world. The potential for eradicating hereditary diseases is enormous. But are the benefits outweighed by the risks involved? And should these techniques ever be used on humans? On Newshour Extra this week, Owen Bennett Jones and his panel of expert guests discuss the scientific and ethical consequences of this latest research, and ask whether mankind should be tinkering with our genetic inheritance.
Contributors: Prof Robin Lovell-Badge - Head of Stem Cell Biology and Developmental Genetics at the Francis Crick Institute; Michael Le Page -New Scientist magazine; Dr Annelien Bredenoord - Associate Professor of Biomedical Ethics at the University Medical Centre in Utrecht; Marcy Darnovsky - Executive Director of the Center for Genetics and Society, Berkeley, California; James Rushbrooke - playwrite; Edward Perello - co-founder of Desktop Genetics
Related Articles
By Ian Sample, The Guardian | 07.04.2024
Biological models of human embryos that can develop heartbeats, spinal cords and other distinctive features will be governed by a code of practice in Britain to ensure that researchers work on them responsibly.
Made from stem cells, they mimic, to...
By Kevin Davies, Genetic Engineering & Biotechnology News | 06.27.2024
Physician-scientist Matthew Porteus, MD, PhD, has been a mainstay in the genome editing field for more than two decades. He trained at Stanford University Medical School before completing his residency and hematology/oncology fellowship at Boston Children’s Hospital/Dana Farber Cancer Institute...
By Peter Aldhous, Scientific American | 07.02.2024
In June a notice posted on the website of the journal Nature set a new scientific record. It withdrew what is now the most highly cited research paper ever to be retracted.
The study, published in 2002 by Catherine Verfaillie...
By Robert F. Service, Science | 07.04.2024
Image by Ed Uthman from Flickr
Last year, the U.S. Food and Drug Administration (FDA) approved two gene therapy procedures that can treat and, in some cases essentially cure sickle cell disease, a genetic blood disorder that causes pain and...